APN/CD13 expression in breast cancer significantly correlated with neoangiogenesis, and OS tended to be shorter in patients with APN/CD13 positive tumors; which suggests that APN/CD13 expression can serve as an indicator of poor prognosis in the evaluation of breast cancer [16]. This evidence concerns the gene ANPEP and breast carcinoma.